| Charles Timothy Stamps, RPH | |
|
820 Brookway Blvd, Brookhaven, MS 39601-2642 | |
| (601) 833-9063 | |
| Not Available |
| Full Name | Charles Timothy Stamps |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 820 Brookway Blvd, Brookhaven, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679929913 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | E6736 (Mississippi) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Charles Timothy Stamps, RPH 1098 Schmidt Rd, Mccomb, MS 39648-8745 Ph: (601) 248-6585 | Charles Timothy Stamps, RPH 820 Brookway Blvd, Brookhaven, MS 39601-2642 Ph: (601) 833-9063 |
News Archive
BioAlliance Pharma SA, a company dedicated to specialty and orphan oncology products, today announces oral communication of the Phase II clinical trial results of its orphan product Livatag at the annual congress of ILCA, the only international organization devoted exclusively to liver cancer research with participation of worldwide best specialists.
The Washington Post Fact Checker takes a closer look at the health law enrollment target the Obama administration is now backing away from. In the meantime, many states continue to confront insurance exchange challenges even after the crush of customers looking to get coverage to start in January.
Want to be sure you are spending your healthcare dollars wisely? Fortunately, the latest version of the Hospital Value Index™ reveals that informed healthcare consumers can find high-value healthcare in every corner of the United States.
Prostate tumors that carry a "signature" of four molecular markers have the potential to become dangerously metastatic if not treated aggressively, researchers at Dana-Farber Cancer Institute report in a study published online today by the journal Nature. The discovery lays the groundwork for the first gene-based test for determining whether a man's prostate cancer is likely to remain dormant within the prostate gland, or spread lethally to other parts of the body.
NovoStent Corporation, a privately held medical device company, today announced the 6-month follow-up results of the company's European clinical trial evaluating the use of its SAMBA Stent and Delivery System in the treatment of superficial femoral and popliteal artery disease. The SAMBA Stent was designed to treat the highly varied presentation of atherosclerotic disease in the superficial femoral (SFA) and popliteal arteries by providing a unique combination of increased vessel coverage, strength and flexibility.
› Verified 5 days ago
Dr. Abby Furr Garcia, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 820 Brookway Blvd, Brookhaven, MS 39601 Phone: 601-833-9063 | |
James Larry Nordin, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 719 Brookway Blvd, Brookhaven, MS 39601 Phone: 601-833-8509 Fax: 601-833-9626 | |
Brandon Baker, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 428 Highway 51 N, Brookhaven, MS 39601 Phone: 601-833-7455 | |
Bill E Blalack, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 218 S Whitworth Ave, Brookhaven, MS 39601 Phone: 601-835-0370 Fax: 601-835-3376 | |
Kembe Keys, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 719 Brookway Blvd, Brookhaven, MS 39601 Phone: 601-833-8509 | |
Jessica Boutwell, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 950 Brookway Blvd, Brookhaven, MS 39601 Phone: 601-833-8436 | |
James Gary Berch, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 820 Brookway Blvd, Brookhaven, MS 39601 Phone: 601-833-9063 |